B-cells with a FasL expressing regulatory phenotype are induced following successful anti-tuberculosis treatment:

Immunity, Inflammation and Disease

Volumn 5, Issue 1, 2017, Pages 57-67

  Van Rensburg, Ilana C ^a   Kleynhans, Léanie ^a   Keyser, Alana ^b   Walzl, Gerhard ^a   Loxton, Andre G ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Apoptosis; broncho alveolar lavage fluid; FasL; immune exhaustion

Indexed keywords

EID: 85034829213     PISSN: None     EISSN: 20504527     Source Type: Journal    
DOI: 10.1002/iid3.140     Document Type: Article

References (38)

1. Du Plessis, W. J., L. Kleynhans, N. du Plessis, K. Stanley, S. T. Malherbe, E. Maasdorp, K. Ronacher, N. N. Chegou, G. Walzl, and, A. G. Loxton,. 2016. The runctional response of B cells to antigenic stimulation: a preliminary report of latent tuberculosis. PLOS ONE 11 (4): e0152710.
2. Lund, F. E., 2008. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin. Immunol. 20 (3): 332-338.
3. Duddy, M., M. Niino, F. Adatia, S. Hebert, M. Freedman, H. Atkins, H. J. Kim, and, A. Bar-Or,. 2007. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178 (10): 6092-6099.
4. Schultze, J. L., S. Michalak, J. Lowne, A. Wong, M. H. Gilleece, J. G. Gribben, and, L. M. Nadler,. 1999. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon γ, and IL-10: role of B cells in the maintenance of T cell responses. J. Exp. Med. 189 (1): 1-12.
5. Gagro, A., D. Servis, A.-M. Cepika, K.-M. Toellner, G. Grafton, D. R. Taylor, S. Branica, and, J. Gordon,. 2006. Type I cytokine profiles of human naive and memory B lymphocytes: a potential for memory cells to impact polarization. Immunology 118 (1): 66-77.
6. Wagner, M., H. Poeck, B. Jahrsdoerfer, S. Rothenfusser, D. Prell, B. Bohle, E. Tuma, T. Giese, J. W. Ellwart, S. Endres, et al., 2004. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J. Immunol. 172 (2): 954-963.
7. Hahne, M., T. Renno, M. Schroeter, M. Irmler, L. French, T. Bornand, H. R. MacDonald, and, J. Tschopp,. 1996. Activated B cells express functional Fas ligand,. Eur. J. Immunol. 26 (3): 721-724.
8. Lundy, S. K., S. P. Lerman, and, D. L. Boros,. 2001. Soluble egg antigen-Stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL+ T and B cells during murine Schistosoma mansoni infection. Infect. Immun. 69 (1): 271-280.
9. Klinker, M. W., T. J. Reed, D. A. Fox, and, S. K. Lundy,. 2013. Interleukin-5 supports the expansion of Fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4+ T Cells and secrete interleukin-10. PLoS ONE 8 (8): e70131.
10. Montandon, R., S. Korniotis, E. Layseca-Espinosa, C. Gras, J. Megret, S. Ezine, M. Dy, and, F. Zavala,. 2013. Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc. Natl. Acad. Sci. 110 (24): E2199-E2208.
11. Bafica, A., C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and, A. Sher,. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202 (12): 1715-1724.
12. Carmona, J., A. Cruz, L. Moreira-Teixeira, C. Sousa, J. Sousa, N. S. Osorio, A. L. Saraiva, S. Svenson, G. Kallenius, J. Pedrosa, et al., 2013. Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on the immune response. PLoS ONE 8 (6): e67277.
13. Kleinnijenhuis, J., M. Oosting, L. A. B. Joosten, M. G. Netea, and, R. Van Crevel,. 2011. Innate immune recognition of Mycobacterium tuberculosis. Clin. Dev. Immunol. 2011: 1-12.
14. Hua, Z., and, B. Hou,. 2013. TLR signaling in B-cell development and activation. Cell. Mol. Immunol. 10 (2): 103-106.
15. Perfetto, S. P., P. K. Chattopadhyay, and, M. Roederer,. 2004. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 4 (8): 648-655.
16. Sedger, L. M., M. B. Glaccum, J. C. Schuh, S. T. Kanaly, E. Williamson, N. Kayagaki, T. Yun, P. Smolak, T. Le, and, R. Goodwin,. 2002. Characterization of the in vivo function of TNF-α-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. Eur. J. Immunol. 32 (8): 2246-2254.
17. Lundy, S. K., 2009. Killer B lymphocytes: the evidence and the potential. Inflamm. Res. Off. J. Eur. Histamine Res. Soc. Al. doi: 10.1007/s00011-009-0014-x
18. Cliff, J. M., J.-S. Lee, N. Constantinou, J.-E. Cho, T. G. Clark, K. Ronacher, E. C. King, P. T. Lukey, P. Van Helden, et al., 2013. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J. Infect. Dis. 207 (1): 18-29.
19. van Rensburg, I. C., C. Wagman, K. Stanley, C. Beltran, K. Ronacher, G. Walzl, and, A. G. Loxton,. 2016. Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA. Oncotarget DOI: 10.18632/oncotarget.12184. [Epub ahead of print] PubMed PMID: 27682872.
20. Reich-Zeliger, S., Y. Zhao, R. Krauthgamer, E. Bachar-Lustig, and, Y. Reisner,. 2000. Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. Immunity 13 (4): 507-515.
21. Rich, R. F., and, W. R. Green,. 2002. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells. J. Immunol. 168 (6): 2751-2758.
22. Oshiba, A., E. Hamelmann, K. Takeda, K. L. Bradley, J. E. Loader, G. L. Larsen, et al., 1996. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J. Clin. Invest. 97 (6): 1398-1408.
23. Lack, G., A. Oshiba, K. L. Bradley, J. E. Loader, D. Amran, G. L. Larsen, and, E. W. Gelfand,. 1995. Transfer of immediate hypersensitivity and airway hyperresponsiveness by IgE-positive B cells. Am. J. Respir. Crit. Care Med. 152 (6): 1765-1773.
24. Haczku, A., K. Takeda, I. Redai, E. Hamelmann, G. Cieslewicz, A. Joetham, J. Loader, J. J. Lee, C. Irvin, and, E. W. Gelfand,. 1999. Anti-CD86 (B7. 2) treatment abolishes allergic airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 159 (5): 1638-1643.
25. Arnaboldi, P. M., M. J. Behr, and, D. W. Metzger,. 2005. Mucosal B cell deficiency in igA-/- mice abrogates the development of allergic lung inflammation. J. Immunol. 175 (2): 1276-1285.
26. Nagafuchi, H., S. Wakisaka, Y. Takeba, M. Takeno, T. Sakane, and, N. Suzuki,. 2002. Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: 'immune privilege'-like state of the autoreactive B cells. Clin. Exp. Rheumatol. 20 (5): 625-631.
27. Akdis, M., A. Trautmann, S. Klunker, I. Daigle, U. C. Küçüksezer, W. Deglmann, R. Disch, K. Blaser, and, C. A. Akdis,. 2003. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J. 17 (9): 1026-1035.
28. Meiler, F., M. Zimmermann, K. Blaser, C. A. Akdis, and, M. Akdis,. 2006. T-cell subsets in the pathogenesis of human asthma. Curr. Allergy Asthma Rep. 6 (2): 91-96.
29. Green, D. R., N. Droin, and, M. Pinkoski,. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193 (1): 70-81.
30. Maher, S., D. Toomey, C. Condron, and, D. Bouchier-Hayes,. 2002. Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol. Cell Biol. 80 (2): 131-137.
31. O'Connell, J., 2000. Immune privilege or inflammation? The paradoxical effects of Fas ligand. Arch. Immunol. Ther. Exp. (Warsz.) 48 (2): 73-79.
32. Macdonald, S. H.-F., E. Woodward, M. M. Coleman, E. R. Dorris, P. Nadarajan, W.-M. Chew, A. McLaughlin, and, J. Keane,. 2012. Networked T cell death following macrophage infection by Mycobacterium tuberculosis. PloS ONE 7 (6): e38488.
33. Zhu, Q., M. Zhang, M. Shi, Y. Liu, Q. Zhao, W. Wang, G. Zhang, L. Yang, J. Zhi, L. Zhang, et al., 2016. Human B cells have an active phagocytic capability and undergo immune activation upon phagocytosis of Mycobacterium tuberculosis. Immunobiology 221 (4): 558-567.
34. García-Pérez, B. E., J. J. De la Cruz-López, J. I. Castañeda-Sánchez, A. R. Muñóz-Duarte, A. D. Hernández-Pérez, H. Villegas-Castrejón, E. García-Latorre, A. Caamal-Ley, and, J. Luna-Herrera,. 2012. Macropinocytosis is responsible for the uptake of pathogenic and non-pathogenic mycobacteria by B lymphocytes (Raji cells). BMC Microbiol. 12: 246.
35. Pilheu, J. A., M. C. De Salvo, J. Gonzalez, D. Rey, M. C. Elias, and, M. C. Ruppi,. 1997. CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection. Int. J. Tuberc. Lung Dis. Off. J. Int. Union Tuberc. Lung Dis. 1 (5): 422-426.
36. Yang, Y., M. Mercep, C. F. Ware, and, J. D. Ashwell,. 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181 (5): 1673-1682.
37. Brunner, T., N. J. Yoo, D. LaFace, C. F. Ware, and, D. R. Green,. 1996. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int. Immunol. 8 (7): 1017-1026.
38. Alderson, M. R., et al., 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181 (1): 71-77.